M Cotelli Selected Research

Dopamine (Intropin)

1/2017	Modulating risky decision-making in Parkinson's disease by transcranial direct current stimulation.
3/2006	Glucose metabolism and dopamine PET correlates in a patient with myotonic dystrophy type 2 and parkinsonism.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

M Cotelli Research Topics

Disease

2	Parkinsonian Disorders (Parkinsonism) 09/2015 - 03/2006
2	Alzheimer Disease (Alzheimer's Disease) 11/2012 - 12/2008
2	Atrophy 12/2010 - 01/2010
1	Gambling (Pathological Gambling) 01/2017
1	Parkinson Disease (Parkinson's Disease) 01/2017
1	Apraxias (Dyspraxia) 09/2015
1	Myoclonus (Nocturnal Myoclonus) 09/2015
1	Dystonia (Limb Dystonia) 09/2015
1	Corticobasal Degeneration 09/2015
1	Ideomotor Apraxia 09/2015
1	Dementia (Dementias) 12/2010
1	Cognitive Dysfunction 12/2008
1	Myotonic Dystrophy (Dystrophia Myotonica) 03/2006

Drug/Important Bio-Agent (IBA)

2	Dopamine (Intropin)FDA LinkGeneric 01/2017 - 03/2006
1	salicylhydroxamic acid (SHAM)IBA 01/2017
1	Levodopa (L Dopa)FDA LinkGeneric 09/2015
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 12/2010
1	NAD (NADH)IBA 12/2010
1	Amyloid (Amyloid Fibrils)IBA 01/2010
1	Glucose (Dextrose)FDA LinkGeneric 03/2006

Therapy/Procedure

2	Transcranial Direct Current Stimulation 01/2017 - 09/2015
2	Transcranial Magnetic Stimulation 11/2012 - 12/2008
1	Therapeutics 01/2017